Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes
- PMID: 22751696
- PMCID: PMC3447890
- DOI: 10.2337/db12-0099
Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes
Abstract
We tested the hypothesis that altered Toll-like receptor (TLR) signaling may be involved in early stages of type 1 diabetes (T1D). To do so, we analyzed TLR-induced interleukin (IL)-1β and IL-6 responses in freshly isolated peripheral blood mononuclear cells (PBMNCs) from seropositive compared with seronegative subjects. Similar frequencies of myeloid dendritic cells (mDCs), plasmacytoid DCs (pDCs), and monocytes were observed in seropositive and seronegative subjects. Subjects with autoantibodies had increased proportions of monocytes expressing IL-1β ex vivo. Activating PBMNCs with TLR3, TLR4, or TLR7/8 agonists in vitro led to increased percentages of IL-1β-expressing monocytes and mDCs from seropositive versus seronegative subjects. TLR ligation also resulted in a diminished IL-6 response in seropositive individuals as lower frequencies of IL-6-expressing monocytes and mDCs were induced. The dysregulated TLR-induced IL-1β and IL-6 pathways were more readily detectable in children aged <11 years and from 11 to <21 years, respectively, and did not involve altered HbA(1c) or the presence of one or more autoantibodies. Finally, subjects with autoantibodies had lower amounts of serum chemokine (C-X-C motif) ligand 10 compared with autoantibody-negative subjects. Our data may imply that alterations in innate immune pathways are detectable in genetically susceptible individuals and could be linked with the early course of T1D.
Figures






Similar articles
-
α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.J Clin Endocrinol Metab. 2014 Aug;99(8):E1418-26. doi: 10.1210/jc.2013-3864. Epub 2014 Feb 14. J Clin Endocrinol Metab. 2014. PMID: 24527714 Free PMC article. Clinical Trial.
-
Altered Toll-like receptor signaling pathways in human type 1 diabetes.J Mol Med (Berl). 2010 Dec;88(12):1221-31. doi: 10.1007/s00109-010-0666-6. Epub 2010 Aug 20. J Mol Med (Berl). 2010. PMID: 20725710
-
TLR activation pathways in HIV-1-exposed seronegative individuals.J Immunol. 2010 Mar 1;184(5):2710-7. doi: 10.4049/jimmunol.0902463. Epub 2010 Feb 1. J Immunol. 2010. PMID: 20124101
-
Interleukin 1-Beta (IL-1β) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients.J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):213-220. doi: 10.1097/QAI.0000000000001181. J Acquir Immune Defic Syndr. 2017. PMID: 27654812 Free PMC article.
-
Nerve growth factor downregulates inflammatory response in human monocytes through TrkA.J Immunol. 2014 Apr 1;192(7):3345-54. doi: 10.4049/jimmunol.1300825. Epub 2014 Feb 28. J Immunol. 2014. PMID: 24585880
Cited by
-
Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?Diabetes. 2018 Aug;67(8):1481-1494. doi: 10.2337/db17-1564. Diabetes. 2018. PMID: 30030289 Free PMC article. Review.
-
Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody.Diabetes. 2015 Oct;64(10):3614-26. doi: 10.2337/db14-1868. Epub 2015 Jun 30. Diabetes. 2015. PMID: 26130764 Free PMC article.
-
Antidiabetic efficacy of lactoferrin in type 2 diabetic pediatrics; controlling impact on PPAR-γ, SIRT-1, and TLR4 downstream signaling pathway.Diabetol Metab Syndr. 2018 Dec 4;10:89. doi: 10.1186/s13098-018-0390-x. eCollection 2018. Diabetol Metab Syndr. 2018. PMID: 30534206 Free PMC article.
-
The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.Int Rev Cell Mol Biol. 2019;345:35-136. doi: 10.1016/bs.ircmb.2018.08.002. Epub 2018 Sep 25. Int Rev Cell Mol Biol. 2019. PMID: 30904196 Free PMC article. Review.
-
Chronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications.PLoS One. 2015 Sep 14;10(9):e0137618. doi: 10.1371/journal.pone.0137618. eCollection 2015. PLoS One. 2015. PMID: 26367738 Free PMC article.
References
-
- Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005. Immunol Rev 2005;204:232–249 - PubMed
-
- Zipris D. Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms. Clin Immunol 2009;131:11–23 - PubMed
-
- Eisenbarth GS, Jeffrey J. The natural history of type 1A diabetes. Arq Bras Endocrinol Metabol 2008;52:146–155 - PubMed
-
- Barker JM. Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 2006;91:1210–1217 - PubMed
-
- Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. Natural history of type 1 diabetes. Diabetes 2005;54(Suppl. 2):S25–S31 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous